Assembly Biosciences Inc (ASMB)
12.90
-0.31
(-2.35%)
USD |
NASDAQ |
May 02, 16:00
12.90
0.00 (0.00%)
After-Hours: 20:00
Assembly Biosciences Enterprise Value: -57.82M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | -57.82M |
| April 30, 2024 | -61.88M |
| April 29, 2024 | -59.52M |
| April 26, 2024 | -60.89M |
| April 25, 2024 | -57.00M |
| April 24, 2024 | -56.34M |
| April 23, 2024 | -57.49M |
| April 22, 2024 | -57.76M |
| April 19, 2024 | -56.72M |
| April 18, 2024 | -57.16M |
| April 17, 2024 | -59.41M |
| April 16, 2024 | -50.64M |
| April 15, 2024 | -48.39M |
| April 12, 2024 | -49.92M |
| April 11, 2024 | -47.68M |
| April 10, 2024 | -49.76M |
| April 09, 2024 | -48.83M |
| April 08, 2024 | -51.29M |
| April 05, 2024 | -54.75M |
| April 04, 2024 | -55.46M |
| April 03, 2024 | -54.64M |
| April 02, 2024 | -56.23M |
| April 01, 2024 | -59.52M |
| March 28, 2024 | -57.33M |
| March 27, 2024 | -56.89M |
| Date | Value |
|---|---|
| March 26, 2024 | -58.64M |
| March 25, 2024 | -57.87M |
| March 22, 2024 | -59.08M |
| March 21, 2024 | -63.36M |
| March 20, 2024 | -62.32M |
| March 19, 2024 | -65.39M |
| March 18, 2024 | -65.55M |
| March 15, 2024 | -63.52M |
| March 14, 2024 | -64.18M |
| March 13, 2024 | -60.94M |
| March 12, 2024 | -60.18M |
| March 11, 2024 | -56.78M |
| March 08, 2024 | -55.79M |
| March 07, 2024 | -57.39M |
| March 06, 2024 | -57.82M |
| March 05, 2024 | -56.50M |
| March 04, 2024 | -57.16M |
| March 01, 2024 | -56.39M |
| February 29, 2024 | -60.12M |
| February 28, 2024 | -60.40M |
| February 27, 2024 | -62.53M |
| February 26, 2024 | -66.76M |
| February 23, 2024 | -68.07M |
| February 22, 2024 | -67.47M |
| February 21, 2024 | -67.80M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-78.96M
Minimum
Dec 03 2021
660.41M
Maximum
Jul 20 2020
67.37M
Average
-17.73M
Median
Enterprise Value Benchmarks
| Petros Pharmaceuticals Inc | -0.3953M |
| Spectral AI Inc | 21.08M |
| NovaBay Pharmaceuticals Inc | 2.654M |
| Palatin Technologies Inc | 20.69M |
| iBio Inc | 16.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.96M |
| Revenue (Quarterly) | 7.163M |
| Total Expenses (Quarterly) | 19.71M |
| EPS Diluted (Quarterly) | -1.999 |
| Profit Margin (Quarterly) | -153.0% |
| Earnings Yield | -104.8% |
| Normalized Earnings Yield | -104.80 |